An interesting article ....
https://www.healio.com/news/gastroe...oms-more-frequently-than-noninfected-controls
Patients with COVID-19 experience GI symptoms more frequently than noninfected controls
In a prospective study, researchers analyzed data from 883 hospitalized patients to investigate the prevalence of GI symptoms and post-COVID-19 disorders of gut-brain interaction (DGBI). They enrolled 269 patients with SARS-CoV-2 infection (mean age, 49.9 years; 59.9% men) and 269 controls (mean age, 50.9 years; 62.1% men), who were assessed for GI symptoms, anxiety and depression at admission and 1, 6 and 12 months after hospitalization. Secondary study endpoints included assessment of post-infection DGBI predictive factors.
- Forums
- ASX - By Stock
- RWE for 2nd MSB COVID-19 ARDS P3 Trial
An interesting article .... ;)...
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.18 |
Change
0.028(2.38%) |
Mkt cap ! $1.353B |
Open | High | Low | Value | Volume |
$1.16 | $1.20 | $1.16 | $7.360M | 6.234M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 98506 | $1.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 43853 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 49666 | 1.185 |
14 | 130989 | 1.180 |
14 | 158375 | 1.175 |
12 | 331233 | 1.170 |
31 | 203998 | 1.165 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 60100 | 11 |
1.195 | 121188 | 10 |
1.200 | 164815 | 12 |
1.205 | 326675 | 14 |
1.210 | 190752 | 20 |
Last trade - 12.43pm 28/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.20 |
  |
Change
0.028 ( 3.73 %) |
|||
Open | High | Low | Volume | ||
$1.17 | $1.20 | $1.16 | 531443 | ||
Last updated 13.02pm 28/05/2024 ? |
Featured News
MSB (ASX) Chart |